CPRX vs ECL · P/E 18, rev $491.7M vs P/E 35, rev $4.01B
Catalyst Pharmaceuticals Inc (CPRX) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Catalyst Pharmaceuticals Inc (CPRX) is a biotechnology company listed on NASDAQ.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported CPRX revenue for 2024-12-31 was $491.7M. Net income was $163.9M. Revenue was up 23.5% from 2023-12-31 to 2024-12-31. CPRX currently screens at market cap $3.84B and trailing P/E 18.2.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
CPRX currently screens at market cap $3.84B and trailing P/E 18.2. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the CPRX and ECL stock pages for the full models.
Not investment advice.